About NanoSynex

Nanosynex is an Israeli biotech startup created in 2017 that aims at providing new solutions to improve testing quality and reduce healthcare costs by speeding up diagnostic processes.

Today, Nanosynex is focused on the development and commercialization of an innovative Antimicrobial Susceptibility Test (AST). The technology is based on a purely phenotypic approach and uses a microfluidic disposable test cartridge platform and method that optimizes bacterial growth. This disruptive development was born from exciting research discoveries at the lab of Professor Shulamit Levenberg, Dean of the Technion Biomedical Engineering Faculty.

Nanosynex team is composed of passionate, dedicated business executives and top-notch engineers and supported by a network of experts, including strategic alliances with future distributors, that know how to bring this revolutionary scientific innovation to the market.

Play Video

TEAM

Advisory board & Kol

AWARDS & RECOGNITION

First place winners of “Suzhou Medtech Global Competition”, organized by TechCode (received a $4K cash prize and a fully subsidized trip to China to join the competition finals and meet potential partners)

Second place winners of “the Shenzhen Innovation and Entrepreneurship International Competition” (received a RMB 130K – ~$18K – cash prize and a fully subsidized trip to China to join the competition finals and meet potential partners)

Winner of the PITCH#5 MEDTECH BOOTCAMP INVESTOR EVENT Received in-kind investment: free legal and professional service providers, partners of the bootcamp
MassChallenge 2017 Class Finalists. Received in-kind investment: free consulting and coaching from Life Science industry and investors experts; free IP review and office space.
SheLovesTech Israeli Finalist